MYH9 Gene Deafness Autosomal Dominant Type 17 NGS Genetic DNA Test
Understanding MYH9-Related Hearing Loss
The MYH9 Gene Deafness Autosomal Dominant Type 17 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for hereditary hearing disorders. This comprehensive test utilizes next-generation sequencing (NGS) technology to analyze the MYH9 gene, which plays a critical role in maintaining the structural integrity of inner ear hair cells. Mutations in this gene can lead to progressive sensorineural hearing loss that typically begins in childhood or early adulthood.
What This Test Detects
Our advanced NGS genetic test specifically identifies:
- Pathogenic variants in the MYH9 gene associated with autosomal dominant nonsyndromic hearing loss
- Specific mutations responsible for DFNA17 hearing impairment
- Genetic markers that predict the progression and severity of hearing loss
- Inheritance patterns to guide family planning decisions
Who Should Consider This Test?
This genetic test is recommended for individuals experiencing:
- Progressive hearing loss beginning in childhood or early adulthood
- Family history of hereditary hearing impairment
- Unexplained sensorineural hearing loss without clear environmental causes
- Planning for pregnancy with family history of hearing disorders
- Children showing early signs of hearing difficulties with family history
Clinical Benefits of Genetic Testing
Undergoing the MYH9 gene test provides numerous advantages:
- Early Intervention: Enables proactive hearing management strategies
- Personalized Treatment: Guides appropriate hearing aid selection and cochlear implant candidacy
- Family Planning: Provides crucial information for genetic counseling
- Accurate Diagnosis: Differentiates between genetic and environmental causes of hearing loss
- Proactive Monitoring: Allows for regular audiological assessments based on genetic risk
Understanding Your Test Results
Our comprehensive genetic counseling support helps you interpret results:
- Positive Result: Indicates presence of MYH9 gene mutation; enables early intervention and family screening
- Negative Result: Suggests hearing loss may have other genetic or environmental causes
- Variant of Uncertain Significance: Requires additional family studies and ongoing research correlation
All results include detailed explanations and recommendations for next steps with our certified genetic counselors.
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | MYH9 Gene Deafness Autosomal Dominant Type 17 NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) Technology |
Convenient Testing Locations Across USA
We have established testing facilities in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services with professional genetic counseling support.
Take Control of Your Hearing Health
Don’t let hereditary hearing loss remain a mystery. Our MYH9 gene test provides the clarity needed for informed healthcare decisions. Early genetic diagnosis can significantly improve quality of life through appropriate interventions and management strategies.
Book your genetic test today by calling our dedicated genetics hotline at +1(267) 388-9828 or schedule your appointment online. Our genetic counselors are available to answer your questions and guide you through the testing process.
